Table 1.

Clinical characteristics of the patients included in this study

Case ACase BCase CCase DCase ECase FCase G
GenderFMFFFMF
Age at diagnosis63775259696054
PS1N/AN/A3222
PathologyDLBCDLBCDLBCDLBCDLBCDLBCDLBC
SubtypeGCGCGCNon-GCNon-GCNon-GCNon-GC
TreatmentCHOD-BLEO + RTNoneHDMTXNoneN/AaN/AaR-MPV
Survival (mo)1052.58+ (alive)<1101226+ (alive)

Abbreviations: PS, performance status; CHOD-BLEO, cyclophosphamide, vincristine, adriamycin, dexamethasone, and bleomycin; RT, radiotherapy; HDMTX, high-dose methotrexate; R-MPV, rituximab, methotrexate, procarbazine, and vincristine; N/A, not available.

  • aPatients treated but details not known.